Foclivia Sospensione iniettabile in un Flaconcino

Valsts: Šveice

Valoda: itāļu

Klimata pārmaiņas: Swissmedic (Swiss Agency for Therapeutic Products)

Aktīvā sastāvdaļa:

haemagglutininum influenzae A (H5N1), neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14)

Pieejams no:

Medius AG

ATĶ kods:

J07BB02

SNN (starptautisko nepatentēto nosaukumu):

haemagglutininum influenzae A (H5N1), neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14)

Zāļu forma:

Sospensione iniettabile in un Flaconcino

Kompozīcija:

haemagglutininum influenzae A (H5N1) et neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14) 7.5 µg, adjuvans MF59C.1: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acidum citricum monohydricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, conserv.: thiomersalum 50 µg, aqua ad iniectabile, q.s. ad suspensionem pro 0.5 ml.

Klase:

B

Ārstniecības grupa:

Vaccini

Ārstniecības joma:

Pandemico Influenzale Vaccino

Autorizācija statuss:

zugelassen

Autorizācija datums:

2018-04-20